Montelukast Cristers

Montelukast, the active ingredient in Montelukast Cristers, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is employed in the maintenance treatment of asthma, relief of allergic rhinitis symptoms, and prevention of exercise‑induced bronchoconstriction in appropriate patients.

GNH USA supplies Montelukast Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Montelukast acts on the leukotriene pathway to manage several respiratory and allergic conditions.

Asthma: Provides maintenance therapy that reduces airway inflammation, improves symptom control, and lowers the frequency of exacerbations. Allergic rhinitis: Relieves nasal congestion, sneezing, itching and watery discharge associated with seasonal or perennial allergic rhinitis. Exercise‑induced bronchoconstriction: Prevents bronchospasm triggered by physical activity, allowing better tolerance of exercise in patients with this condition.

Montelukast may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Abdominal pain - Cough - Nausea

Serious or Rare Side Effects: - Angioedema - Mood changes, including depression or suicidal thoughts - Anaphylaxis

When prescribing Montelukast, clinicians should consider several precautionary measures to ensure safe use.

Assess asthma control: confirm that patients are on appropriate inhaled therapy before adding Montelukast. Monitor neuropsychiatric symptoms: watch for mood changes, depression or suicidal ideation during treatment. Check for hypersensitivity: avoid use in individuals with known allergy to Montelukast or any tablet excipients. Use with caution in hepatic impairment: dose adjustment may be required in patients with liver dysfunction. Store at room temperature: keep in the original packaging, protect from moisture and excessive heat.

Montelukast can interact with other medicines that affect its metabolism or plasma concentrations.

Major Interactions (Avoid): - Ritonavir: may increase Montelukast plasma levels, raising risk of side effects. - Phenobarbital: may reduce Montelukast effectiveness by inducing metabolism. - Carbamazepine: may lower Montelukast concentrations, diminishing therapeutic benefit.

Moderate Interactions (Monitor Closely): - Fluconazole: may modestly increase Montelukast levels; monitor for adverse effects. - Warfarin: may alter INR; regular coagulation monitoring is advised.